Researchers analyzed data from 18 clinical trials involving nearly 4,500 patients who suffered from spontaneous intracerebral hemorrhage. The study compared several surgical techniques, including minimally invasive puncture surgery (MIPS), endoscopic surgery (ES), decompressive craniectomy (DC), and traditional craniotomy (CC), against standard medical treatment.
The findings suggest that both MIPS and ES were linked to better functional outcomes at six months compared to traditional craniotomies and medical treatment alone. While these methods showed fewer complications during surgery, such as less blood loss and shorter operation times, the evidence for decompressive craniectomy (DC) remains uncertain regarding its specific role in survival.
Because this was a large-scale analysis of existing trials rather than a single new trial, the results are not definitive. More high-quality studies are needed to confirm exactly which surgery is best for different patients. Patients and doctors should view these findings as an indication that less invasive techniques may improve recovery times and surgical safety.
Common questions
What are the benefits of minimally invasive surgery for brain bleeds?
Minimally invasive puncture surgery (MIPS) and endoscopic surgery (ES) were linked to better functional outcomes at six months compared to traditional craniotomies. These methods also significantly reduced operative time and blood loss during the procedure, which may reduce the burden on the patient during surgery.
How do different surgical techniques compare for brain bleeds?
The study found that MIPS and ES performed similarly well for functional recovery. While endoscopic surgery (ES) showed higher hematoma clearance rates, it also resulted in shorter hospital stays. Decompressive craniectomy (DC) ranked highest for potential survival, though more research is needed to confirm these results.
Is the evidence for all treatments certain?
The evidence for some treatments is not yet fully clear. Specifically, the role of decompressive craniectomy (DC) in mortality remains uncertain because many comparisons did not reach statistical significance. More high-quality trials are needed to determine the best treatment for every patient.